Viewing Study NCT03326102


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-02-28 @ 9:43 PM
Study NCT ID: NCT03326102
Status: COMPLETED
Last Update Posted: 2024-02-16
First Post: 2017-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
Sponsor: Daehwa Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent or Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None DHP107 View
None Paclitaxel View
None Liporaxel View